nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—ESR1—AP-1 transcription factor network—TH—peripheral nervous system neoplasm	0.00142	0.00544	CbGpPWpGaD
Danazol—CCL2—TWEAK Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.00139	0.00533	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—CASP3—peripheral nervous system neoplasm	0.00137	0.00526	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	0.00133	0.00511	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.00129	0.00496	CbGpPWpGaD
Danazol—ESR1—Nuclear signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	0.00128	0.00493	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	0.00127	0.00488	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.00126	0.00486	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00118	0.00453	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—TP53—peripheral nervous system neoplasm	0.00116	0.00445	CbGpPWpGaD
Danazol—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00116	0.00157	CcSEcCtD
Danazol—ESR1—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.00116	0.00444	CbGpPWpGaD
Danazol—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.00115	0.00441	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—NRAS—peripheral nervous system neoplasm	0.00115	0.00441	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.00114	0.0044	CbGpPWpGaD
Danazol—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.00155	CcSEcCtD
Danazol—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00112	0.00152	CcSEcCtD
Danazol—CCL2—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.00112	0.00431	CbGpPWpGaD
Danazol—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00112	0.00152	CcSEcCtD
Danazol—Fluid retention—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00152	CcSEcCtD
Danazol—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.00112	0.00152	CcSEcCtD
Danazol—CCL2—IL-1 signaling pathway—AKT1—peripheral nervous system neoplasm	0.00112	0.0043	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.00111	0.00426	CbGpPWpGaD
Danazol—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.0015	CcSEcCtD
Danazol—Vertigo—Vincristine—peripheral nervous system neoplasm	0.0011	0.00149	CcSEcCtD
Danazol—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.0011	0.00149	CcSEcCtD
Danazol—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.00149	CcSEcCtD
Danazol—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.0011	0.00149	CcSEcCtD
Danazol—Urticaria—Topotecan—peripheral nervous system neoplasm	0.0011	0.00149	CcSEcCtD
Danazol—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.0011	0.00149	CcSEcCtD
Danazol—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00109	0.00148	CcSEcCtD
Danazol—CCL2—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	0.00109	0.0042	CbGpPWpGaD
Danazol—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00109	0.00148	CcSEcCtD
Danazol—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00109	0.00148	CcSEcCtD
Danazol—AR—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.00108	0.00417	CbGpPWpGaD
Danazol—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.00147	CcSEcCtD
Danazol—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00108	0.00147	CcSEcCtD
Danazol—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.00147	CcSEcCtD
Danazol—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.00146	CcSEcCtD
Danazol—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00108	0.00146	CcSEcCtD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00108	0.00414	CbGpPWpGaD
Danazol—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00107	0.00146	CcSEcCtD
Danazol—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00106	0.00144	CcSEcCtD
Danazol—Flushing—Etoposide—peripheral nervous system neoplasm	0.00106	0.00144	CcSEcCtD
Danazol—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00106	0.00144	CcSEcCtD
Danazol—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00143	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00106	0.00406	CbGpPWpGaD
Danazol—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00143	CcSEcCtD
Danazol—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00141	CcSEcCtD
Danazol—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00104	0.00141	CcSEcCtD
Danazol—GNRHR—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00103	0.00397	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00102	0.00394	CbGpPWpGaD
Danazol—Chills—Etoposide—peripheral nervous system neoplasm	0.00102	0.00139	CcSEcCtD
Danazol—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00139	CcSEcCtD
Danazol—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00139	CcSEcCtD
Danazol—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00102	0.00138	CcSEcCtD
Danazol—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00138	CcSEcCtD
Danazol—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00138	CcSEcCtD
Danazol—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00137	CcSEcCtD
Danazol—Alopecia—Etoposide—peripheral nervous system neoplasm	0.00101	0.00137	CcSEcCtD
Danazol—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.001	0.00136	CcSEcCtD
Danazol—Oedema—Vincristine—peripheral nervous system neoplasm	0.001	0.00136	CcSEcCtD
Danazol—ESR1—FOXM1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000999	0.00384	CbGpPWpGaD
Danazol—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000991	0.00134	CcSEcCtD
Danazol—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000984	0.00133	CcSEcCtD
Danazol—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000984	0.00133	CcSEcCtD
Danazol—CCL2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000983	0.00378	CbGpPWpGaD
Danazol—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00098	0.00133	CcSEcCtD
Danazol—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000979	0.00133	CcSEcCtD
Danazol—CCL2—Oncostatin M Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000978	0.00376	CbGpPWpGaD
Danazol—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000978	0.00133	CcSEcCtD
Danazol—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000975	0.00132	CcSEcCtD
Danazol—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000971	0.00132	CcSEcCtD
Danazol—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000971	0.00132	CcSEcCtD
Danazol—AR—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.00097	0.00373	CbGpPWpGaD
Danazol—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00097	0.00131	CcSEcCtD
Danazol—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00097	0.00131	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000968	0.00372	CbGpPWpGaD
Danazol—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000968	0.00131	CcSEcCtD
Danazol—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000966	0.00131	CcSEcCtD
Danazol—AR—Coregulation of Androgen receptor activity—CDKN2A—peripheral nervous system neoplasm	0.000962	0.0037	CbGpPWpGaD
Danazol—Back pain—Etoposide—peripheral nervous system neoplasm	0.000961	0.0013	CcSEcCtD
Danazol—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000957	0.0013	CcSEcCtD
Danazol—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000955	0.00129	CcSEcCtD
Danazol—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000947	0.00128	CcSEcCtD
Danazol—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00094	0.00127	CcSEcCtD
Danazol—GNRHR—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000937	0.0036	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.000933	0.00359	CbGpPWpGaD
Danazol—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000933	0.00126	CcSEcCtD
Danazol—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00092	0.00125	CcSEcCtD
Danazol—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000914	0.00124	CcSEcCtD
Danazol—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000914	0.00124	CcSEcCtD
Danazol—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000912	0.00124	CcSEcCtD
Danazol—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.00091	0.00123	CcSEcCtD
Danazol—Migraine—Epirubicin—peripheral nervous system neoplasm	0.00091	0.00123	CcSEcCtD
Danazol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000906	0.00123	CcSEcCtD
Danazol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000906	0.00123	CcSEcCtD
Danazol—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000899	0.00122	CcSEcCtD
Danazol—GNRHR—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000899	0.00345	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000897	0.00345	CbGpPWpGaD
Danazol—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000896	0.00121	CcSEcCtD
Danazol—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000893	0.00121	CcSEcCtD
Danazol—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000889	0.00121	CcSEcCtD
Danazol—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000888	0.0012	CcSEcCtD
Danazol—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000886	0.0012	CcSEcCtD
Danazol—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000885	0.0012	CcSEcCtD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000884	0.0034	CbGpPWpGaD
Danazol—AR—Nongenotropic Androgen signaling—HRAS—peripheral nervous system neoplasm	0.00088	0.00338	CbGpPWpGaD
Danazol—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000879	0.00119	CcSEcCtD
Danazol—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000876	0.00119	CcSEcCtD
Danazol—CCL2—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.000875	0.00336	CbGpPWpGaD
Danazol—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000873	0.00118	CcSEcCtD
Danazol—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000872	0.00118	CcSEcCtD
Danazol—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000872	0.00118	CcSEcCtD
Danazol—Rash—Topotecan—peripheral nervous system neoplasm	0.000871	0.00118	CcSEcCtD
Danazol—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00087	0.00118	CcSEcCtD
Danazol—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000867	0.00117	CcSEcCtD
Danazol—Headache—Topotecan—peripheral nervous system neoplasm	0.000866	0.00117	CcSEcCtD
Danazol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000864	0.00117	CcSEcCtD
Danazol—Rash—Tretinoin—peripheral nervous system neoplasm	0.000864	0.00117	CcSEcCtD
Danazol—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000864	0.00117	CcSEcCtD
Danazol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000864	0.00117	CcSEcCtD
Danazol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000864	0.00117	CcSEcCtD
Danazol—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000863	0.00117	CcSEcCtD
Danazol—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000861	0.00117	CcSEcCtD
Danazol—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00086	0.00117	CcSEcCtD
Danazol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000859	0.00116	CcSEcCtD
Danazol—Headache—Tretinoin—peripheral nervous system neoplasm	0.000859	0.00116	CcSEcCtD
Danazol—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000858	0.00116	CcSEcCtD
Danazol—Constipation—Vincristine—peripheral nervous system neoplasm	0.000856	0.00116	CcSEcCtD
Danazol—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000856	0.00116	CcSEcCtD
Danazol—Rash—Melphalan—peripheral nervous system neoplasm	0.000853	0.00116	CcSEcCtD
Danazol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000852	0.00116	CcSEcCtD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00085	0.00327	CbGpPWpGaD
Danazol—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000845	0.00115	CcSEcCtD
Danazol—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000842	0.00114	CcSEcCtD
Danazol—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000842	0.00114	CcSEcCtD
Danazol—CCL2—TNF alpha Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000839	0.00322	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.000836	0.00321	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000835	0.00321	CbGpPWpGaD
Danazol—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000825	0.00112	CcSEcCtD
Danazol—PGR—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	0.000824	0.00317	CbGpPWpGaD
Danazol—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000821	0.00111	CcSEcCtD
Danazol—Nausea—Topotecan—peripheral nervous system neoplasm	0.000821	0.00111	CcSEcCtD
Danazol—GNRHR—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000821	0.00316	CbGpPWpGaD
Danazol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000814	0.0011	CcSEcCtD
Danazol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000814	0.0011	CcSEcCtD
Danazol—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000811	0.0011	CcSEcCtD
Danazol—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000806	0.00109	CcSEcCtD
Danazol—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000804	0.00109	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000804	0.00309	CbGpPWpGaD
Danazol—Nausea—Melphalan—peripheral nervous system neoplasm	0.000804	0.00109	CcSEcCtD
Danazol—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000795	0.00108	CcSEcCtD
Danazol—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000794	0.00108	CcSEcCtD
Danazol—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000791	0.00107	CcSEcCtD
Danazol—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000791	0.00107	CcSEcCtD
Danazol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000791	0.00107	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000789	0.00303	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000785	0.00302	CbGpPWpGaD
Danazol—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000784	0.00106	CcSEcCtD
Danazol—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000784	0.00106	CcSEcCtD
Danazol—GNRHR—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000782	0.00301	CbGpPWpGaD
Danazol—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000782	0.00106	CcSEcCtD
Danazol—AR—Nongenotropic Androgen signaling—AKT1—peripheral nervous system neoplasm	0.000777	0.00299	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000777	0.00299	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—peripheral nervous system neoplasm	0.000775	0.00298	CbGpPWpGaD
Danazol—CCL2—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	0.000772	0.00297	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—PTPN11—peripheral nervous system neoplasm	0.00076	0.00292	CbGpPWpGaD
Danazol—ESR1—Estrogen signaling pathway—AKT1—peripheral nervous system neoplasm	0.00076	0.00292	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000747	0.00287	CbGpPWpGaD
Danazol—CYP19A1—FSH signaling pathway—AKT1—peripheral nervous system neoplasm	0.000747	0.00287	CbGpPWpGaD
Danazol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000745	0.00101	CcSEcCtD
Danazol—PGR—Gene Expression—EED—peripheral nervous system neoplasm	0.000743	0.00286	CbGpPWpGaD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—NRAS—peripheral nervous system neoplasm	0.000741	0.00285	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000741	0.00285	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	0.000736	0.00283	CbGpPWpGaD
Danazol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000735	0.000996	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000733	0.00282	CbGpPWpGaD
Danazol—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000732	0.000993	CcSEcCtD
Danazol—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00073	0.000989	CcSEcCtD
Danazol—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000728	0.000987	CcSEcCtD
Danazol—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000727	0.000986	CcSEcCtD
Danazol—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000725	0.000983	CcSEcCtD
Danazol—CCL2—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000719	0.00276	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.000719	0.00276	CbGpPWpGaD
Danazol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000718	0.000974	CcSEcCtD
Danazol—GNRHR—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000718	0.00276	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000717	0.00276	CbGpPWpGaD
Danazol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000712	0.000966	CcSEcCtD
Danazol—GNRHR—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00071	0.00273	CbGpPWpGaD
Danazol—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000707	0.000958	CcSEcCtD
Danazol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000706	0.000958	CcSEcCtD
Danazol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.0007	0.000949	CcSEcCtD
Danazol—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000699	0.000948	CcSEcCtD
Danazol—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000695	0.000942	CcSEcCtD
Danazol—Constipation—Etoposide—peripheral nervous system neoplasm	0.000693	0.00094	CcSEcCtD
Danazol—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000692	0.00266	CbGpPWpGaD
Danazol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000687	0.000931	CcSEcCtD
Danazol—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000683	0.000926	CcSEcCtD
Danazol—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.00068	0.000921	CcSEcCtD
Danazol—ESR1—FOXM1 transcription factor network—MYC—peripheral nervous system neoplasm	0.000677	0.0026	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.000676	0.0026	CbGpPWpGaD
Danazol—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000675	0.000915	CcSEcCtD
Danazol—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000673	0.000912	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000671	0.00258	CbGpPWpGaD
Danazol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000666	0.000902	CcSEcCtD
Danazol—ESR1—LKB1 signaling events—MYC—peripheral nervous system neoplasm	0.000664	0.00255	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000664	0.00255	CbGpPWpGaD
Danazol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000662	0.000897	CcSEcCtD
Danazol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000661	0.000895	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.00066	0.00254	CbGpPWpGaD
Danazol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000659	0.00253	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000656	0.00252	CbGpPWpGaD
Danazol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000655	0.000888	CcSEcCtD
Danazol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000654	0.000887	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000654	0.000886	CcSEcCtD
Danazol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000651	0.000882	CcSEcCtD
Danazol—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000644	0.000873	CcSEcCtD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	0.000643	0.00247	CbGpPWpGaD
Danazol—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000643	0.000872	CcSEcCtD
Danazol—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000643	0.000871	CcSEcCtD
Danazol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000641	0.000869	CcSEcCtD
Danazol—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00064	0.000867	CcSEcCtD
Danazol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000636	0.000863	CcSEcCtD
Danazol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000635	0.000861	CcSEcCtD
Danazol—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000632	0.000857	CcSEcCtD
Danazol—Rash—Vincristine—peripheral nervous system neoplasm	0.000631	0.000856	CcSEcCtD
Danazol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000631	0.000855	CcSEcCtD
Danazol—ESR1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.00063	0.00242	CbGpPWpGaD
Danazol—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000629	0.000852	CcSEcCtD
Danazol—Headache—Vincristine—peripheral nervous system neoplasm	0.000627	0.00085	CcSEcCtD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000619	0.00238	CbGpPWpGaD
Danazol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000617	0.000837	CcSEcCtD
Danazol—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000617	0.000836	CcSEcCtD
Danazol—CCL2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000605	0.00233	CbGpPWpGaD
Danazol—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000605	0.00082	CcSEcCtD
Danazol—ESR1—Leptin signaling pathway—ERBB2—peripheral nervous system neoplasm	0.000601	0.00231	CbGpPWpGaD
Danazol—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000595	0.000807	CcSEcCtD
Danazol—Nausea—Vincristine—peripheral nervous system neoplasm	0.000595	0.000806	CcSEcCtD
Danazol—PGR—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000594	0.00228	CbGpPWpGaD
Danazol—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000594	0.000805	CcSEcCtD
Danazol—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000592	0.000803	CcSEcCtD
Danazol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000582	0.000789	CcSEcCtD
Danazol—PGR—Signaling by ERBB4—ERBB2—peripheral nervous system neoplasm	0.000582	0.00224	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00058	0.00223	CbGpPWpGaD
Danazol—Chills—Epirubicin—peripheral nervous system neoplasm	0.000574	0.000778	CcSEcCtD
Danazol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000574	0.000778	CcSEcCtD
Danazol—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000571	0.000773	CcSEcCtD
Danazol—AR—Gene Expression—EED—peripheral nervous system neoplasm	0.000566	0.00218	CbGpPWpGaD
Danazol—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000565	0.000766	CcSEcCtD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000564	0.00217	CbGpPWpGaD
Danazol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000563	0.000763	CcSEcCtD
Danazol—CYP19A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000561	0.00216	CbGpPWpGaD
Danazol—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00056	0.000759	CcSEcCtD
Danazol—Rash—Cisplatin—peripheral nervous system neoplasm	0.000558	0.000757	CcSEcCtD
Danazol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000558	0.000756	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000554	0.00213	CbGpPWpGaD
Danazol—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000549	0.000745	CcSEcCtD
Danazol—Tension—Epirubicin—peripheral nervous system neoplasm	0.000547	0.000741	CcSEcCtD
Danazol—ESR1—LKB1 signaling events—TP53—peripheral nervous system neoplasm	0.000546	0.0021	CbGpPWpGaD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—HRAS—peripheral nervous system neoplasm	0.000542	0.00208	CbGpPWpGaD
Danazol—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000541	0.000733	CcSEcCtD
Danazol—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000539	0.00073	CcSEcCtD
Danazol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000536	0.000727	CcSEcCtD
Danazol—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000535	0.000726	CcSEcCtD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000532	0.00204	CbGpPWpGaD
Danazol—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000531	0.00072	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000531	0.00204	CbGpPWpGaD
Danazol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000526	0.000713	CcSEcCtD
Danazol—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000525	0.000712	CcSEcCtD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—peripheral nervous system neoplasm	0.000525	0.00202	CbGpPWpGaD
Danazol—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000523	0.000709	CcSEcCtD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	0.00052	0.002	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000517	0.00199	CbGpPWpGaD
Danazol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000516	0.000699	CcSEcCtD
Danazol—Rash—Etoposide—peripheral nervous system neoplasm	0.000511	0.000693	CcSEcCtD
Danazol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000511	0.000692	CcSEcCtD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000508	0.00195	CbGpPWpGaD
Danazol—Headache—Etoposide—peripheral nervous system neoplasm	0.000508	0.000689	CcSEcCtD
Danazol—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000506	0.000686	CcSEcCtD
Danazol—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000501	0.000679	CcSEcCtD
Danazol—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.0005	0.000678	CcSEcCtD
Danazol—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000499	0.000677	CcSEcCtD
Danazol—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000499	0.000676	CcSEcCtD
Danazol—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000499	0.000676	CcSEcCtD
Danazol—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.000672	CcSEcCtD
Danazol—ESR1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.000494	0.0019	CbGpPWpGaD
Danazol—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000492	0.000667	CcSEcCtD
Danazol—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00049	0.000664	CcSEcCtD
Danazol—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000486	0.000658	CcSEcCtD
Danazol—ESR1—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	0.000483	0.00186	CbGpPWpGaD
Danazol—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000483	0.000654	CcSEcCtD
Danazol—Nausea—Etoposide—peripheral nervous system neoplasm	0.000482	0.000653	CcSEcCtD
Danazol—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000481	0.000652	CcSEcCtD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	0.000479	0.00184	CbGpPWpGaD
Danazol—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000474	0.000643	CcSEcCtD
Danazol—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000473	0.000641	CcSEcCtD
Danazol—GNRHR—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000464	0.00178	CbGpPWpGaD
Danazol—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000463	0.000628	CcSEcCtD
Danazol—Ethinyl Estradiol—ABCB1—peripheral nervous system neoplasm	0.000462	0.212	CrCbGaD
Danazol—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.000627	CcSEcCtD
Danazol—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000461	0.000625	CcSEcCtD
Danazol—CCL2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000461	0.00177	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—MYC—peripheral nervous system neoplasm	0.00046	0.00177	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000459	0.00176	CbGpPWpGaD
Danazol—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000455	0.000617	CcSEcCtD
Danazol—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000455	0.000616	CcSEcCtD
Danazol—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.000614	CcSEcCtD
Danazol—AR—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000452	0.00174	CbGpPWpGaD
Danazol—AR—Coregulation of Androgen receptor activity—AKT1—peripheral nervous system neoplasm	0.000452	0.00174	CbGpPWpGaD
Danazol—Prednisone—ABCB1—peripheral nervous system neoplasm	0.000451	0.207	CrCbGaD
Danazol—ESR1—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	0.00045	0.00173	CbGpPWpGaD
Danazol—Shock—Epirubicin—peripheral nervous system neoplasm	0.000447	0.000606	CcSEcCtD
Danazol—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000447	0.000605	CcSEcCtD
Danazol—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000445	0.000603	CcSEcCtD
Danazol—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000603	CcSEcCtD
Danazol—Norethindrone—ABCB1—peripheral nervous system neoplasm	0.000445	0.204	CrCbGaD
Danazol—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000444	0.000601	CcSEcCtD
Danazol—PGR—Signaling by ERBB4—NRAS—peripheral nervous system neoplasm	0.000443	0.0017	CbGpPWpGaD
Danazol—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000439	0.000596	CcSEcCtD
Danazol—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.000595	CcSEcCtD
Danazol—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000437	0.000593	CcSEcCtD
Danazol—ESR1—Gene Expression—EED—peripheral nervous system neoplasm	0.000436	0.00168	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	0.000432	0.00166	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000423	0.00163	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000421	0.00162	CbGpPWpGaD
Danazol—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.00057	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.00042	0.00161	CbGpPWpGaD
Danazol—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000414	0.000561	CcSEcCtD
Danazol—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.000561	CcSEcCtD
Danazol—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.000558	CcSEcCtD
Danazol—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000411	0.000556	CcSEcCtD
Danazol—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000553	CcSEcCtD
Danazol—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000551	CcSEcCtD
Danazol—GNRHR—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000406	0.00156	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000404	0.00155	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000403	0.00155	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	0.0004	0.00154	CbGpPWpGaD
Danazol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.0004	0.000542	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000394	0.00151	CbGpPWpGaD
Danazol—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000531	CcSEcCtD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000389	0.0015	CbGpPWpGaD
Danazol—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000389	0.000527	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000387	0.00149	CbGpPWpGaD
Danazol—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000519	CcSEcCtD
Danazol—CYP19A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000379	0.00146	CbGpPWpGaD
Danazol—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000512	CcSEcCtD
Danazol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.000502	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	0.000369	0.00142	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000369	0.00142	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000368	0.00142	CbGpPWpGaD
Danazol—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000492	CcSEcCtD
Danazol—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000361	0.00049	CcSEcCtD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	0.00036	0.00139	CbGpPWpGaD
Danazol—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.000488	CcSEcCtD
Danazol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000487	CcSEcCtD
Danazol—PGR—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000349	0.00134	CbGpPWpGaD
Danazol—ESR1—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000349	0.00134	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000348	0.00134	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—ERBB2—peripheral nervous system neoplasm	0.000341	0.00131	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000335	0.00129	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000335	0.00129	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—HRAS—peripheral nervous system neoplasm	0.000334	0.00129	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—AKT1—peripheral nervous system neoplasm	0.000334	0.00128	CbGpPWpGaD
Danazol—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000453	CcSEcCtD
Danazol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000451	CcSEcCtD
Danazol—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000442	CcSEcCtD
Danazol—PGR—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	0.000324	0.00124	CbGpPWpGaD
Danazol—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000436	CcSEcCtD
Danazol—ESR1—Regulation of Telomerase—AKT1—peripheral nervous system neoplasm	0.000319	0.00123	CbGpPWpGaD
Danazol—Hydrocortisone—ABCB1—peripheral nervous system neoplasm	0.000318	0.146	CrCbGaD
Danazol—CCL2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000318	0.00122	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000316	0.00121	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000315	0.00121	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000312	0.0012	CbGpPWpGaD
Danazol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000409	CcSEcCtD
Danazol—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000407	CcSEcCtD
Danazol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000403	CcSEcCtD
Danazol—ESR1—Leptin signaling pathway—AKT1—peripheral nervous system neoplasm	0.000295	0.00114	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000291	0.00112	CbGpPWpGaD
Danazol—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000392	CcSEcCtD
Danazol—Rash—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000389	CcSEcCtD
Danazol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000388	CcSEcCtD
Danazol—PGR—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	0.000286	0.0011	CbGpPWpGaD
Danazol—Headache—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000386	CcSEcCtD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000284	0.00109	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.00028	0.00108	CbGpPWpGaD
Danazol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000377	CcSEcCtD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	0.000278	0.00107	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GNS—peripheral nervous system neoplasm	0.000274	0.00105	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000272	0.00105	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000272	0.00104	CbGpPWpGaD
Danazol—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000366	CcSEcCtD
Danazol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000363	CcSEcCtD
Danazol—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000359	CcSEcCtD
Danazol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000359	CcSEcCtD
Danazol—PGR—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000265	0.00102	CbGpPWpGaD
Danazol—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000357	CcSEcCtD
Danazol—CYP19A1—Metabolism—NME1—peripheral nervous system neoplasm	0.000262	0.00101	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000262	0.00101	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—NRAS—peripheral nervous system neoplasm	0.00026	0.000999	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000259	0.000997	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000259	0.000997	CbGpPWpGaD
Danazol—Progesterone—ABCB1—peripheral nervous system neoplasm	0.000259	0.119	CrCbGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000258	0.000992	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000256	0.000984	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—COX2—peripheral nervous system neoplasm	0.000253	0.000971	CbGpPWpGaD
Danazol—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000339	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000249	0.000956	CbGpPWpGaD
Danazol—Testosterone—ABCB1—peripheral nervous system neoplasm	0.000245	0.112	CrCbGaD
Danazol—PGR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000244	0.000939	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000243	0.000935	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000238	0.000914	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000237	0.000912	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000223	0.000858	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000219	0.000842	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000218	0.000836	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000215	0.000826	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000205	0.000788	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000202	0.000775	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	0.0002	0.000768	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000196	0.000755	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	0.00019	0.000731	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000188	0.000724	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000183	0.000705	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000181	0.000698	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	0.000171	0.000656	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000169	0.000648	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000168	0.000647	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	0.000168	0.000645	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000166	0.000638	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000166	0.000636	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000165	0.000636	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000164	0.000629	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000157	0.000603	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000155	0.000597	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000154	0.000592	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000151	0.000581	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.00015	0.000575	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000143	0.000551	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—BCHE—peripheral nervous system neoplasm	0.00014	0.000539	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.00014	0.000537	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000137	0.000527	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000134	0.000514	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TH—peripheral nervous system neoplasm	0.000132	0.000507	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000131	0.000502	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	0.00013	0.0005	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000123	0.000473	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000119	0.000459	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000119	0.000456	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000113	0.000433	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000111	0.000425	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000109	0.000421	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000109	0.000418	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000108	0.000417	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000108	0.000414	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000108	0.000414	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000106	0.000406	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	0.0001	0.000385	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.94e-05	0.000382	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.94e-05	0.000382	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.53e-05	0.000367	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.26e-05	0.000356	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	9.21e-05	0.000354	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.09e-05	0.000349	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.78e-05	0.000337	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.47e-05	0.000326	CbGpPWpGaD
Danazol—PGR—Gene Expression—MYC—peripheral nervous system neoplasm	8.21e-05	0.000316	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.05e-05	0.00031	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	7.99e-05	0.000307	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	7.66e-05	0.000294	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.6e-05	0.000292	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.54e-05	0.00029	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	7.37e-05	0.000283	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.27e-05	0.00028	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.95e-05	0.000267	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.84e-05	0.000263	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.65e-05	0.000256	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.42e-05	0.000247	CbGpPWpGaD
Danazol—AR—Gene Expression—MYC—peripheral nervous system neoplasm	6.26e-05	0.000241	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.87e-05	0.000226	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.73e-05	0.00022	CbGpPWpGaD
Danazol—PGR—Gene Expression—AKT1—peripheral nervous system neoplasm	5.7e-05	0.000219	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.6e-05	0.000215	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.34e-05	0.000205	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.84e-05	0.000186	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MYC—peripheral nervous system neoplasm	4.82e-05	0.000185	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.42e-05	0.00017	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.39e-05	0.000169	CbGpPWpGaD
Danazol—AR—Gene Expression—AKT1—peripheral nervous system neoplasm	4.34e-05	0.000167	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.19e-05	0.000161	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	4.09e-05	0.000157	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.01e-05	0.000154	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.9e-05	0.00015	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.85e-05	0.000148	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.7e-05	0.000142	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.36e-05	0.000129	CbGpPWpGaD
Danazol—ESR1—Gene Expression—AKT1—peripheral nervous system neoplasm	3.34e-05	0.000129	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.14e-05	0.000121	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.13e-05	0.00012	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.08e-05	0.000118	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.9e-05	0.000112	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.57e-05	9.89e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.46e-05	9.46e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.17e-05	8.36e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	8.47e-06	3.26e-05	CbGpPWpGaD
